P & G

Navigenics has added a new medications feature to its service offerings and is providing customers with a wallet-sized report that contains a condensed version of the genetic response to as many as 12 prescription drugs, which the company began reporting as part of its DTC service this week.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.